Calluna Pharma
Calluna Pharma is developing first-in-class therapies designed to defeat chronic inflammation and fibrosis at the source.
$81M Series A ·
Source: startupintros.com
Funding history ↓Signals
Website registeredOct 24, 2023 (3 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $81M | — | startupintros.com |
Timeline
- Website created
Team
MS
Margrethe Sørgaard Senior Vice President Clinical Operations & PV
Acquisitions
| Acquired company | Price | Announced |
|---|---|---|
| Not disclosed publicly | Date not given | |
| Not disclosed publicly | Date not given |
Investors
Companies like Calluna Pharma
GGranite Bio$30M Series A · Apr 2025
VVandria$30.7M Series A · Aug 2024LLuofang BiotechnologySeed · Apr 2026
RRoca TherapeuticsSeed · Sep 2022LLifeCyte Innovations$1M Seed · Aug 2026
RRougeTx$58M Series A · Oct 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/calluna-pharma (get a free API key).